Treatment of inoperable ovarian cancer with interleukin-2 and carboplatinum

Lancet. 1995 Dec 16;346(8990):1627. doi: 10.1016/s0140-6736(95)91959-7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Carboplatin / administration & dosage*
  • Combined Modality Therapy
  • Cystadenocarcinoma, Papillary / therapy*
  • Female
  • Humans
  • Interleukin-2 / administration & dosage*
  • Ovarian Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Interleukin-2
  • Carboplatin